Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,073 | 14 | 98.0% |
| Education | $21.73 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $439.78 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $198.59 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $137.14 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.80 | 1 | $0 (2024) |
| HeartFlow, Inc. | $29.50 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $21.73 | 1 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $18.07 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.80 | 2 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $149.99 | 1 | Janssen Pharmaceuticals, Inc ($149.99) |
| 2022 | $35.86 | 2 | Regeneron Healthcare Solutions, Inc. ($21.73) |
| 2020 | $11.54 | 1 | Janssen Pharmaceuticals, Inc ($11.54) |
| 2019 | $240.07 | 3 | Novartis Pharmaceuticals Corporation ($123.01) |
| 2018 | $124.58 | 2 | Amgen Inc. ($105.11) |
| 2017 | $282.77 | 4 | Amgen Inc. ($247.11) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: DIABETES | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/20/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $87.56 | General |
| Category: Cardiology | ||||||
| 09/17/2019 | HeartFlow, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| 05/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $123.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $105.11 | General |
| Category: Cardiology | ||||||
| 01/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: Cardiology | ||||||
| 08/08/2017 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,121 | 1,691 | $301,510 | $143,478 |
| 2022 | 7 | 1,065 | 1,750 | $314,610 | $156,744 |
| 2021 | 8 | 943 | 1,619 | $281,145 | $142,298 |
| 2020 | 8 | 725 | 1,274 | $215,880 | $98,742 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 605 | $96,735 | $60,797 | 62.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 215 | 218 | $87,200 | $36,520 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 264 | $23,760 | $18,172 | 76.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 71 | 71 | $33,725 | $14,721 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $22,500 | $8,019 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 233 | 360 | $34,200 | $4,300 | 12.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 62 | 113 | $3,390 | $949.20 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 253 | 684 | $109,655 | $72,329 | 66.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 205 | 209 | $83,600 | $37,041 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 248 | $22,320 | $17,436 | 78.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 77 | 77 | $36,575 | $15,987 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 76 | 76 | $28,500 | $9,720 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 196 | 312 | $29,640 | $3,803 | 12.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 144 | $4,320 | $427.89 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 214 | 630 | $100,800 | $67,307 | 66.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 172 | 174 | $69,600 | $31,096 | 44.7% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 74 | 74 | $35,150 | $15,965 | 45.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 208 | $18,720 | $14,595 | 78.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $21,375 | $7,638 | 35.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 168 | 284 | $26,980 | $3,611 | 13.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 23 | $3,450 | $1,579 | 45.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 77 | 169 | $5,070 | $507.00 | 10.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 168 | 509 | $81,440 | $44,477 | 54.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 123 | 124 | $49,600 | $23,105 | 46.6% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2020 | 44 | 45 | $21,375 | $9,171 | 42.9% |
About Dr. Guilda Sarraf, M.D
Dr. Guilda Sarraf, M.D is a Specialist healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396928586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guilda Sarraf, M.D has received a total of $1,095 in payments from pharmaceutical and medical device companies, with $249.80 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,073).
As a Medicare-enrolled provider, Sarraf has provided services to 3,854 Medicare beneficiaries, totaling 6,334 services with total Medicare billing of $541,262. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Torrance, CA
- Active Since 12/11/2007
- Last Updated 08/30/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1396928586
Products in Payments
- Repatha (Biological) $439.78
- XARELTO (Drug) $198.59
- ENTRESTO (Drug) $137.14
- FARXIGA (Drug) $125.00
- JARDIANCE (Drug) $124.80
- EVKEEZA (Biological) $21.73
- Edarbi (Drug) $18.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Torrance
Dr. William Kim, M.d, M.D
Specialist — Payments: $167,651
Dr. Peter Borden, Md, MD
Specialist — Payments: $88,354
Dr. Sutha Sachar, Md, MD
Specialist — Payments: $23,126
Michael Arnstein, M.d, M.D
Specialist — Payments: $13,983
Dr. Hala Koudsi, M.d, M.D
Specialist — Payments: $9,366
Dr. Munish Lal, Md, MD
Specialist — Payments: $6,495